Clinical Trials Sponsored by Abbott Biologicals

Total 2938 results

Abbott

Completed

A Long Term Safety Study With Atrasentan

Adenocarcinoma | Prostate Cancer

Canada, United States, France, Netherlands, United Kingdom
Abbott

Completed

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Abbott

Withdrawn

A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma

Asthma
Abbott

Completed

A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy Male and Female Moderate Alcohol Drinkers

Drug Interactions

Canada
Abbott

Completed

A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections

Mild to Moderate Uncomplicated Skin and Skin Structure Infections
Abbott

Completed

An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) (RHAPSODY)

Ankylosing Spondylitis

France, Germany, Greece, Italy, Switzerland, Spain, United Kingdom, Belgium, Austria, Netherlands, Norway, Denmark, Finland, Ireland, Sweden
Abbott

Completed

Quality of Life Study With Adalimumab in Rheumatoid Arthritis

Rheumatoid Arthritis
Abbott

Completed

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

HIV Infections

United States, Canada
Abbott

Completed

Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis

Kidney Failure, Chronic

Greece
Abbott

Completed

Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease (CHARM)

Crohn's Disease

United States
Abbott

Completed

A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.

Obesity
Abbott

Completed

Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Abbott

Completed

Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis

Psoriatic Arthritis

United States
Abbott

Completed

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
Abbott

Completed

Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) (STEREO)

Psoriatic Arthritis

United States
Abbott

Completed

Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

Carcinoma, Renal Cell

United States, Netherlands
Abbott

Completed

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

Lymphoma, Non-Hodgkin | Hodgkin's Lymphoma

United States
Abbott

Completed

Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents

Bipolar I Disorder, Manic or Mixed

United States
Abbott

Completed

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

HIV Infections

United States
Abbott

Completed

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Crohn's Disease

United States, Canada, Belgium, France
Abbott

Completed

An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents

Bipolar Disorder

United States
Abbott

Terminated

A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children

Partial Seizure Disorder

United States
Abbott

Withdrawn

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

HIV Infection | Hepatitis C
Abbott
Abbott Japan Co.,Ltd

Completed

Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis

Secondary Hyperparathyroidism | Chronic Kidney Disease on Hemodialysis

Japan
Abbott Products
Quintiles, Inc.

Completed

A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes

Type 2 Diabetes

Bulgaria, Poland, South Africa
Abbott Products
Quintiles, Inc.

Terminated

A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.

Traumatic Brain Injury

United States, Israel, Italy, Spain
Abbott
Abbott Japan Co.,Ltd

Completed

Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)

Hemodialysis | Secondary Hyperparathyroidism

Japan
Abbott Products
Quintiles, Inc.

Terminated

First in Man Study With SLV342

Pharmacokinetics

United Kingdom
Abbott
Abbott Japan Co.,Ltd

Completed

A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults

Hepatitis C

Japan
Abbott
Abbott Japan Co.,Ltd

Completed

A Study of Single Dose of ABT-333 in Healthy Male Adults

HCV Infections

Japan
Solvay Biologicals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.

Influenza

Belgium, Germany
Abbott Nutrition

Recruiting

Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition

Diabetes | Malnutrition

Spain
Abbott Nutrition

Recruiting

Oral Rehydration Solutions in Healthy Adult Athletes

Hydration

United States
Abbott Molecular

Completed

Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening

Human Papillomavirus

United States
Abbott Nutrition

Active, not recruiting

Nutrition Intervention in Older Adults at Risk of Malnutrition

Malnutrition

Thailand
Abbott Nutrition

Completed

Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula

Infant Development

United States
Abbott Nutrition

Terminated

Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy

Cow's Milk Allergy

United States
Abbott Nutrition

Completed

An Observational Study of a Nutritional Supplement in an Older Malnourished or at Risk of Malnutrition, Hip Fracture Population

Malnutrition

Spain
Abbott Nutrition

Terminated

Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula

Gastro-Intestinal Tolerance

United States
Abbott Nutrition

Terminated

Infants Fed an Amino Acid-based Formula

Food Allergy

United Kingdom
Abbott Nutrition

Completed

Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk for Malnutrition

Gastrointestinal Tolerance

United Kingdom
Abbott Nutrition

Completed

Growth and Tolerance of Young Infants Fed Infant Formula

Growth and Tolerance

United States
Abbott Nutrition

Completed

Growth and Tolerance of Infants Fed Milk-Based Infant Formula

Gastro-Intestinal Tolerance

United States
Abbott Nutrition

Completed

A Tube Feeding Study in Malnourished Population With Diabetes

Malnutrition; Diabetes

Spain
Abbott Nutrition

Completed

Evaluation of Glucose Control in Patients With Diabetes

Glycemic Control

United States
Abbott Nutrition

Completed

Evaluation of Carbohydrates Part 2

Gastro-Intestinal Tolerance

Canada
Abbott
Almedis

Completed

IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice (PRESTO)

Headache Disorders, Primary | Tension-Type Headache | Migraine Without Aura | Migraine With Aura

Kazakhstan, Ukraine
Abbott Nutrition

Completed

Carbohydrates and Children

Carbohydrate Metabolism

United States
Abbott Nutrition

Completed

Evaluation of Human Milk Fortifiers in Preterm Infants

Infant Growth

United States
Abbott Nutrition

Completed

Effect of Nutritional Products in Subjects With Type 2 Diabetes

Diabetes

United States

3

Subscribe